Furthermore, in gliomas with an IDH mutation, mutant IDH proteins are ubiquitously expressed in tumour cells, suggesting that IDH mutations are an early causative event in the genesis of these brain tumours [46]. The gene discussed is IDH2; the disease is central nervous system cancer.